MedTrace Logo

Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy

NCT00083902 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2010-07-02

No results posted yet for this study

Summary

The purpose of this investigational trial is to find out how well patients respond and how long their response lasts when treated with a standard regimen of dexamethasone with or without thalidomide and also find out what kind of side effects patients will experience.

Conditions

Interventions

DRUG

Thalidomide

DRUG

Dexamethasone

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Maurizio Zangari, M.D. · UAMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-06-30
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00083902 on ClinicalTrials.gov